Major Depressive Disorder: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,850 matching trials) · https://research.opensourcemed.info/briefs/major-depressive-disorder.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Escitalopram 5 trials
- Liafensine (BMS-820836) 4 trials
- Duloxetine 3 trials
- Fluoxetine 2 trials
- 18FAV45 1 trial
- Amibegron (SR58611A) 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Transcranial brain stimulation (tDCS, TMS) 188 trials · 44 completed · 14 with results
- Cognitive behavioural and related therapies 79 trials · 34 completed · 9 with results
- Omega-3 fatty acids and fish oil 14 trials · 7 completed · 6 with results
- Psychotherapy, counselling and peer support 43 trials · 18 completed · 3 with results
- Education, coaching and self-management 25 trials · 13 completed · 3 with results
- Care coordination, navigation and outreach 9 trials · 6 completed · 3 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Probiotics
- Vitamin D3
- Magnesium
- Vitamin B12
- Omega-3 Fatty Acids
- Zinc
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- 25-Hydroxyvitamin D lower · He et al. 2020
- BDNF lower · Nobis et al. 2020
- Cortisol higher · Nobis et al. 2020
- CRP higher · Jarkas et al. 2024
- Homocysteine higher · Harikaran et al. 2024
- IL-6 higher · Jarkas et al. 2024
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder NCT07226661
- A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy… NCT07901179
- Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via… NCT06136546
- Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease… NCT06338215
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders NCT00018057
- Intern Health Study 2026 NCT07685925
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Exercise and physical activity: mood, anxiety and wellbeing 20 trials, no results posted yet
- Neuromodulation and electrical stimulation: cognition 19 trials, no results posted yet